跳至主要内容
临床试验/NCT02647892
NCT02647892终止4 期

Optimal Lidocaine Buffering to Reduce Injection Pain in Local Anesthesia

University of Nebraska1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2016年1月8日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
终止
入组人数
70
试验地点
1
主要终点
Injection pain

研究概览

简要总结

The purpose of this study is to determine the optimal amount of lidocaine buffering needed to decrease injection pain when administering local anesthesia.

详细描述

Once the site is chosen, the skin will be anesthetized as usual. This study will utilize a commercially prepared 1% lidocaine solution mixed with standard sodium bicarbonate. A total of 10 mL will be used.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
19 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • adults presenting for routine thyroid biopsy, paracentesis or thoracentesis in interventional radiology

排除标准

  • Patients requiring sedation
  • Patients with altered mental status
  • Patients allergic to lidocaine or sodium bicarbonate

研究组 & 干预措施

Arm D

Active Comparator

5 mg/mL 50% sodium bicarbonate-50% lidocaine Frequency: 1

干预措施: sodium bicarbonate (Drug)

Arm A

Active Comparator

10 mg/mL lidocaine; Frequency: 1

干预措施: lidocaine (Drug)

Arm B

Active Comparator

9 mg/mL of 10% sodium bicarbonate-90% lidocaine; Frequency: 1

干预措施: lidocaine (Drug)

Arm B

Active Comparator

9 mg/mL of 10% sodium bicarbonate-90% lidocaine; Frequency: 1

干预措施: sodium bicarbonate (Drug)

Arm C

Active Comparator

7.5 mg/Ml of 25% sodium bicarbonate-75% lidocaine Frequency: 1

干预措施: lidocaine (Drug)

Arm C

Active Comparator

7.5 mg/Ml of 25% sodium bicarbonate-75% lidocaine Frequency: 1

干预措施: sodium bicarbonate (Drug)

Arm D

Active Comparator

5 mg/mL 50% sodium bicarbonate-50% lidocaine Frequency: 1

干预措施: lidocaine (Drug)

结局指标

主要结局

Injection pain

时间窗: 6 months

numeric pain scale

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验